SCHEMBL19980910

SCHEMBL19980910

CNC1(F)CCCCC1c1ccc(Cl)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 14/20 0.42
SLC6A3 Q01959 14/20 0.42
SLC6A2 P23975 8/20 0.40
KCNH2 Q12809 3/20 0.40
CYP2D6 P10635 2/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
CYP3A4 P08684 2/20 0.38
NPC1 O15118 1/20 0.38
MLNR O43193 1/20 0.38
NR1I2 O75469 1/20 0.38
ABCB11 O95342 1/20 0.38
ESR1 P03372 1/20 0.38
CYP1A2 P05177 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
ABCB1 P08183 1/20 0.38
ADRB1 P08588 1/20 0.38
HTR1A P08908 1/20 0.38
CHRM5 P08912 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13983003 0.77 SLC6A4 (0.44) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL19051914 0.75 SLC6A4 (0.52) SLC6A4SLC6A3SLC6A2
SCHEMBL19051913 0.71 SLC6A3 (0.40) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL19051501 0.68
Methyl Alcohol SCHEMBL9580463 0.67 SLC6A2 (0.41) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL5903022 0.66 SLC6A3 (0.39) SLC6A4SLC6A3SLC6A2
SCHEMBL5903241 0.66 SLC6A3 (0.40) SLC6A4SLC6A3SLC6A2
SCHEMBL15335800 0.65 SLC6A2 (0.70) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL21586875 0.63 SLC6A2 (0.46) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6
SCHEMBL4331978 0.63 SLC6A2 (0.68) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3296289-A2 PHENYL SUBSTITUTED CYCLOALKYLAMINES AS MONOAMINE REUPTAKE INHIBITORS Sunovion Pharmaceuticals Inc. (US) 2018-03-21 EP disclosed